## Abstract Although it is often assumed that the antitumor effects of nonsteroidal antiβinflammatory drugs (NSAIDs) are due to inhibition of cyclooxgenase (COX) activity, specifically COXβ2, there is accumulating evidence that COXβ2 independent mechanisms can also play an important role. Studies w
Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression
β Scribed by Iman Osman; Jie Dai; Maryann Mikhail; Daniel Navarro; Samir S. Taneja; Peng Lee; Paul Christos; Ruoqian Shen; David M. Nanus
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 347 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
BACKGROUND. Inhibition of protein kinase C (PKC) and modulation of transforming growth factor-β€ (TGF-β€) are both associated with tamoxifen treatment, and both appear to be important in the regulation of prostate cancer cell growth. Investigations were performed which sought to measure the efficacy,
BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a
Paraffin sections from 190 epithelial ovarian tumours, including 159 malignant and 31 benign epithelial tumours, were analysed immunohistochemically for expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16 INK4A (p16). Most benign tumours showed no p16 expression in the tumour